$810 Million is the total value of Redmile Group, LLC's 56 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 88.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $48,644,000 | +46.1% | 647,287 | +22.2% | 6.00% | +19.7% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $34,491,000 | +20.4% | 572,270 | +21.4% | 4.26% | -1.4% |
| ZBH | New | ZIMMER HLDGS INC | $34,260,000 | – | 367,640 | +100.0% | 4.23% | – |
| CELG | Buy | CELGENE CORP | $30,923,000 | +103.7% | 183,018 | +85.6% | 3.82% | +66.9% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $30,345,000 | +147.5% | 511,120 | +116.5% | 3.74% | +102.8% |
| B108PS | New | ACTAVIS PLC | $28,936,000 | – | 172,240 | +100.0% | 3.57% | – |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $23,882,000 | +30.8% | 230,673 | -32.2% | 2.95% | +7.2% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $23,105,000 | – | 182,561 | +100.0% | 2.85% | – |
| INCY | New | INCYTE CORP | $22,733,000 | – | 448,998 | +100.0% | 2.80% | – |
| ARRY | Buy | ARRAY BIOPHARMA INC | $22,348,000 | -2.1% | 4,460,688 | +21.6% | 2.76% | -19.8% |
| AGN | Buy | ALLERGAN INC | $22,186,000 | +9221.8% | 199,727 | +7502.9% | 2.74% | +7505.6% |
| GMED | Buy | GLOBUS MED INCcl a | $21,928,000 | +70.6% | 1,086,637 | +47.6% | 2.71% | +39.8% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $21,306,000 | – | 400,870 | +100.0% | 2.63% | – |
| HTWR | Buy | HEARTWARE INTL INC | $20,861,000 | +53.9% | 222,023 | +19.9% | 2.57% | +26.1% |
| KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $20,777,000 | +99.2% | 557,761 | +144.4% | 2.56% | +63.2% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $20,323,000 | +254.1% | 8,648,087 | +249.6% | 2.51% | +190.3% |
| HCA | Buy | HCA HOLDINGS INC | $19,995,000 | +12.9% | 419,100 | +1.1% | 2.47% | -7.5% |
| THC | Sell | TENET HEALTHCARE CORP | $19,434,000 | -20.2% | 461,402 | -21.9% | 2.40% | -34.6% |
| OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $18,342,000 | – | 946,457 | +100.0% | 2.26% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $18,159,000 | – | 265,949 | +100.0% | 2.24% | – |
| RCPT | Buy | RECEPTOS INC | $18,123,000 | +3256.1% | 625,133 | +2905.4% | 2.24% | +2660.5% |
| NUVA | Sell | NUVASIVE INC | $17,811,000 | +4.9% | 550,914 | -20.5% | 2.20% | -14.0% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $16,683,000 | – | 205,300 | +100.0% | 2.06% | – |
| PFE | New | PFIZER INC | $16,418,000 | – | 536,000 | +100.0% | 2.03% | – |
| ARAY | Buy | ACCURAY INC | $15,197,000 | +91.5% | 1,744,811 | +62.5% | 1.88% | +56.9% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $14,953,000 | +422.6% | 359,977 | +118.1% | 1.84% | +328.1% |
| New | MERCK & CO INC NEWcall | $14,139,000 | – | 282,500 | +100.0% | 1.74% | – | |
| FRX | New | FOREST LABS INC | $13,693,000 | – | 228,100 | +100.0% | 1.69% | – |
| PODD | Sell | INSULET CORP | $13,469,000 | -38.0% | 363,036 | -39.4% | 1.66% | -49.2% |
| CERS | Buy | CERUS CORP | $13,258,000 | -3.7% | 2,055,574 | +0.2% | 1.64% | -21.1% |
| STJ | Sell | ST JUDE MED INC | $13,206,000 | -62.6% | 213,164 | -67.6% | 1.63% | -69.3% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $13,010,000 | +56.8% | 754,660 | +0.1% | 1.60% | +28.5% |
| HWAY | Buy | HEALTHWAYS INC | $12,992,000 | +51.6% | 846,413 | +82.8% | 1.60% | +24.2% |
| CMRX | Buy | CHIMERIX INC | $11,278,000 | -21.5% | 746,405 | +14.2% | 1.39% | -35.7% |
| OPHT | New | OPHTHOTECH CORP | $10,239,000 | – | 316,521 | +100.0% | 1.26% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $9,634,000 | – | 397,951 | +100.0% | 1.19% | – |
| WOOF | Buy | VCA ANTECH INC | $9,602,000 | +21.4% | 306,200 | +6.3% | 1.18% | -0.5% |
| TRNX | Sell | TORNIER N V | $9,162,000 | -16.6% | 487,577 | -14.2% | 1.13% | -31.6% |
| ILMN | New | ILLUMINA INC | $9,035,000 | – | 81,674 | +100.0% | 1.12% | – |
| SIRO | New | SIRONA DENTAL SYSTEMS INC | $8,735,000 | – | 124,425 | +100.0% | 1.08% | – |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $7,857,000 | +91.4% | 3,988,200 | +513.9% | 0.97% | +57.0% |
| NXTM | New | NXSTAGE MEDICAL INC | $6,908,000 | – | 690,770 | +100.0% | 0.85% | – |
| BSTC | Sell | BIOSPECIFICS TECHNOLOGIES CO | $6,199,000 | -2.5% | 286,057 | -12.4% | 0.76% | -20.1% |
| ELGX | New | ENDOLOGIX INC | $5,506,000 | – | 315,733 | +100.0% | 0.68% | – |
| XOMA | New | XOMA CORP DEL | $5,257,000 | – | 781,176 | +100.0% | 0.65% | – |
| AMBI | New | AMBIT BIOSCIENCES CORP | $5,263,000 | – | 545,985 | +100.0% | 0.65% | – |
| VCRA | Buy | VOCERA COMMUNICATIONS INC | $4,439,000 | -2.7% | 284,400 | +15.9% | 0.55% | -20.2% |
| FMI | New | FOUNDATION MEDICINE INC | $2,622,000 | – | 110,092 | +100.0% | 0.32% | – |
| MODN | New | MODEL N INC | $1,077,000 | – | 91,307 | +100.0% | 0.13% | – |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $345,000 | +10.9% | 6,500 | 0.0% | 0.04% | -8.5% | |
| IHF | New | ISHARESus hlthcr pr etf | $280,000 | – | 3,000 | +100.0% | 0.04% | – |
| REGN | Sell | REGENERON PHARMACEUTICALS | $275,000 | -98.9% | 1,000 | -98.8% | 0.03% | -99.1% |
| PRTA | New | PROTHENA CORP PLC | $241,000 | – | 9,100 | +100.0% | 0.03% | – |
| DYAX | New | DYAX CORP | $188,000 | – | 25,000 | +100.0% | 0.02% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $166,000 | – | 35,000 | +100.0% | 0.02% | – |
| MRK | Buy | MERCK & CO INC NEW | $120,000 | +33.3% | 2,400 | +26.3% | 0.02% | +7.1% |
| PRGO | Exit | PERRIGO CO | $0 | – | -1,700 | -100.0% | -0.03% | – |
| RPRX | Exit | REPROS THERAPEUTICS INC | $0 | – | -10,500 | -100.0% | -0.04% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -31,000 | -100.0% | -0.06% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -53,100 | -100.0% | -0.22% | – |
| Exit | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $0 | – | -3,000,000 | -100.0% | -0.52% | – | |
| XON | Exit | INTREXON CORP | $0 | – | -203,600 | -100.0% | -0.73% | – |
| SSH | Exit | SUNSHINE HEART INC | $0 | – | -470,900 | -100.0% | -0.82% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -108,262 | -100.0% | -1.24% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -1,574,379 | -100.0% | -1.31% | – |
| ARTC | Exit | ARTHROCARE CORP | $0 | – | -342,759 | -100.0% | -1.84% | – |
| CSU | Exit | CAPITAL SR LIVING CORP | $0 | – | -597,300 | -100.0% | -1.90% | – |
| MRK | Exit | MERCK & CO INC NEWcall | $0 | – | -282,500 | -100.0% | -2.03% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -465,900 | -100.0% | -2.18% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -757,800 | -100.0% | -3.00% | – |
| ARIA | Exit | ARIAD PHARMACEUTICALS INC | $0 | – | -1,264,009 | -100.0% | -3.50% | – |
| CTRX | Exit | CATAMARAN CORP | $0 | – | -508,100 | -100.0% | -3.52% | – |
| CBST | Exit | CUBIST PHARMACEUTICALS INC | $0 | – | -452,600 | -100.0% | -4.33% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -345,700 | -100.0% | -5.83% | – |
| ACT | Exit | ACTAVIS INC | $0 | – | -271,500 | -100.0% | -5.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.